Apimeds Pharmaceuticals US files initial beneficial ownership statement for co-CEO Sungjoon Chae
APUS•Apimeds Pharmaceuticals US Co-CEO Sungjoon Chae filed an initial statement of beneficial ownership.
1. Ownership filing
Apimeds Pharmaceuticals US Co-CEO Sungjoon Chae filed an initial statement of beneficial ownership.
